Dilip Shanghvi
$27.7B
Born
Oct 01, 1955
Age
69
Source of Wealth
Pharmaceuticals
Residence
Mumbai,
Citizenship
India
Marital Status
Married
Children
2
Education
Bachelor of Arts/Science, Calcutta University
- The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs.
- The company is India's most valuable listed pharma outfit and gets two-thirds of its $5.3 billion annual revenue from overseas markets.
- He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion.
- In 2023, Sun Pharma completed the $576 million acquisition of U.S.-based Concert Pharmaceuticals.
- Photos of Shanghvi's family deity, Shrinathji, adorn Sun's factories and offices.
- Shanghvi 's favorite cuisine is south Indian.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|---|---|---|---|---|
| BSE INDIA | 532872-IN | Sun Pharma Advanced Research | 207,000,000 | 1.70 | INR |
| BSE INDIA | 524715-IN | Sun Pharmaceutical Industries Ltd. | 1,263,100,000 | 20.05 | INR |
| BSE INDIA | 532667-IN | Suzlon Energy Ltd. | 468,500,000 | 0.67 | INR |